US approves Regeneron antibody treatment given to Trump

November 21, 2020
The green light for drugmaker Regeneron came after REGEN-COV2, a combination of two lab-made antibodies, was shown to reduce Covid-19-related hospitalizations or emergency room visits in patients with underlying conditions.

Post a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.